Table 1.

Current active phase II and III trials in NMIUC

Agent(s)SettingTrialaCorrelates
DTA-H19/PEIPhase IIb, second lineNCT00595088
SunitinibPhase II, second lineNCT01118351CTCs, Tregs, angiogenic markers
MCCPhase II/IIINCT00406068
BCG ± gefitinibPhase IIINCT00352079
Intravesicular nab-paclitaxelPhase I/IINCT00583349

Abbreviations: CTC, circulating tumor cell; Treg, regulatory T cell.

  • aClinicalTrials.gov registry number.